Position in SPRY
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$64,240,000
-$7,990,000 QoQ
Shares Held
8,000,000
+29.0% QoQ
Ownership
8.06%
of shares outstanding
% of Portfolio
0.81%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2022
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SPRY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Rubric Capital Management LP holds $938,577,278 across 18 Biotechnology names. SPRY ranks #4 (6.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARQT |
Arcutis Biotherapeutics, Inc.
|
8,271,577 | $194,878,354 | |
| 2 | ZYME |
Zymeworks Inc.
|
7,000,000 | $175,280,000 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
5,000,000 | $138,500,000 | |
| 4 | SPRY |
ARS Pharmaceuticals, Inc.
This page
|
8,000,000 | $64,240,000 | |
| 5 | MGTX |
MeiraGTx Holdings plc
|
7,000,000 | $60,620,000 | |
| 6 | PRTA |
Prothena Corp Public Ltd Co
|
5,000,000 | $48,600,000 | |
| 7 | PTGX |
Protagonist Therapeutics, Inc
|
427,998 | $45,110,989 | |
| 8 | TRVI |
Trevi Therapeutics, Inc.
|
3,712,373 | $44,288,609 |
All Filings in SPRY
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $64,240,000 | 8,000,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $72,230,000 | 6,200,000 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $45,225,000 | 4,500,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $22,595,621 | 1,294,878 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $12,946,090 | 1,029,101 | Shares | Sole | 2025-05-14 | |
| 2024-06-30 | $5,439,617 | 639,203 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $6,532,654 | 639,203 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $3,502,832 | 639,203 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $2,416,187 | 639,203 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $18,754,660 | 2,799,203 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $22,659,435 | 3,480,712 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $25,509,510 | 2,990,564 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $14,230,497 | 2,695,170 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,182,560 | 986,453 | Shares | Sole | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||